<DOC>
	<DOC>NCT00681668</DOC>
	<brief_summary>The purpose of the study is to evaluate the efficacy and tolerability of quetiapine in female patients with postpartum depressive disorder with psychotic symptoms</brief_summary>
	<brief_title>Quetiapine in Postpartum Depression</brief_title>
	<detailed_description />
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depression, Postpartum</mesh_term>
	<mesh_term>Quetiapine Fumarate</mesh_term>
	<criteria>Provision of signed informed consent. Female patients with severe postpartum depressive disorders with psychotic symptoms and a minimum HAMD cut off score of 20 points Woman with preexisting psychotic disorder Patients with alcohol or substance abuse or dependence Patients who pose an imminent risk of suicide or danger to self or others</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>39 Years</maximum_age>
	<verification_date>December 2010</verification_date>
	<keyword>Postpartum Depression</keyword>
	<keyword>Quetiapine</keyword>
	<keyword>Psychotic Symptoms</keyword>
</DOC>